Logan C. Ganzen

This study screens FDA-approved drugs in a zebrafish model of autosomal dominant retinitis pigmentosa, identifying four compounds that improve visual behavior by distinct mechanisms.

The paper shows that retinoic acid receptor inhibition restores synaptic function in bipolar cells of RP models, improving visual signal transmission.

The paper shows that On-cone bipolar cells use NaV channels from coupled amacrine cells to enhance signal transmission in dim light.

This study screens drugs using zebrafish visual behavior to identify carvedilol as a potential treatment for retinitis pigmentosa.